Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study
Open Access
- 2 June 2021
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (13) , 9073-9083
Abstract
Background: This study aimed to compare treatment strategies and survival of patients with synchronous colorectal peritoneal metastases (CPM) and patients with metachronous CPM in a nationwide cohort. Methods: All patients from the Netherlands Cancer Registry with synchronous or metachronous CPM whose primary colorectal cancer (CRC) was diagnosed between 1 January and 30 June 2015 were included in the study. Treatments were categorized as (A) cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [CRS-HIPEC]; (B) palliative treatment; or (C) best supportive care. Overall survival (OS) for all the patients and disease-free survival (DFS) for those who underwent CRS-HIPEC were compared between the two groups. Results: Of 7233 patients, 743 had a diagnosis of CPM, including 409 patients with synchronous CPM and 334 patients with metachronous CPM. The median OS was 8.1 months for the patients with synchronous CPM versus 12 months for the patients with metachronous CPM (p = 0.003). After multivariable correction, OS no longer differed between the patients with synchronous CPM and those with metachronous CPM (HR 1.03 [0.83–1.27]). The patients with metachronous CPM more often underwent CRS-HIPEC than the patients with synchronous CPM (16 % vs 8 %; p = 0.001). The two groups did not differ statistically in terms of DFS and OS (median DFS, 21.5 vs 14.1 months, respectively; p = 0.094; median OS, 37.8 vs. 35.8 months, respectively; p = 0.553). Conclusion: This population-based study showed that survival for the patients with synchronous CPM and patients with metachronous CPM did not significantly differ. This suggests that a similar prognosis may be expected for patients selected for treatment regardless of the onset of CPM.Keywords
This publication has 29 references indexed in Scilit:
- Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancerEuropean Journal of Surgical Oncology, 2014
- Peritoneal carcinomatosis is less frequently diagnosed during laparoscopic surgery compared to open surgery in patients with colorectal cancerEuropean Journal of Surgical Oncology, 2014
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision makingAnnals of Oncology, 2012
- Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE studyInternational Journal of Cancer, 2011
- Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population‐based studyInternational Journal of Cancer, 2010
- Author CorrectionJournal of Clinical Oncology, 2010
- Peritoneal Colorectal Carcinomatosis Treated With Surgery and Perioperative Intraperitoneal Chemotherapy: Retrospective Analysis of 523 Patients From a Multicentric French StudyJournal of Clinical Oncology, 2010
- Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosisJournal of Surgical Oncology, 2008
- Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancerBritish Journal of Surgery, 2002
- Peritoneal carcinomatosis from colorectal cancerBritish Journal of Surgery, 2002